In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
1835 News Items found
Dr. Urvi Shah is seen smiling at the camera.
MSK Research Reveals Connection Between Diet and Cancer

Learn more about how a clinical trial at MSK revealed important connections between the foods we eat and our cancer risk.
Clinical Update
MSK cellular therapist Heather Landau
CAR T Cell Therapy for Light Chain (AL) Amyloidosis Achieves Strong Results

Read about a CAR T cell therapy that appears effective against light chain (AL) amyloidosis.
Article
MSK myeloma specialist and cellular therapist Saad Usmani, MD
New Extramedullary Myeloma Treatment With Bispecific Antibodies Improves Survival Dramatically

Read about a new treatment combining bispecific antibodies that is effective against extramedullary myeloma.
Michael with his granddaughter on a boat
New Treatment for Relapsed Follicular Lymphoma Approved by FDA After MSK-Led Clinical Trial

A phase 3 trial led by MSK showed that adding epcoritamab to traditional treatment for follicular lymphoma benefits patients. Epcoritamab received FDA approval based on the findings.
MSK breast cancer patient Majiel Baker is seen at the beach with her husband and children.
Cancer Care Worth Traveling For: Why People Come to MSK From Across the Country

Learn why over 5,000 people a year travel more than 150 miles to MSK for cancer care, including resources for the specific needs of traveling patients and their loved ones.
Breast medical oncologist Sherry Shen is seen smiling outdoors.
Cancer Benefits and Risks From Ozempic, Wegovy, and Other Weight Loss Drugs

Learn what Zepbound, Wegovy, Ozempic and other weight loss drugs mean for cancer risk and treatment, from an expert at MSK.
Q&A
Dr. Omar Abdel-Wahab in his lab
Meet Omar Abdel-Wahab: A 2025 Paul Marks Prize Recipient 

A leader in developing better treatments for a range of blood cancers, Dr. Omar Abdel-Wahab is only the second person from MSK to receive the Paul Marks Prize for Cancer Research. 
Jack Georgakis is seen wrestling in a martial arts class.
FDA Approves Adding Durvalumab Immunotherapy to Prevent Stomach and Esophageal Cancer Recurrence

Learn about a new approach helping to reduce the risk of stomach and esophageal cancer coming back after surgery, which has been approved by the FDA thanks to a clinical trial with immunotherapy led by researchers at MSK.
MSK patient Karren Tyler poses in front of a portrait of two dogs
Able To Speak After Tongue Cancer, Thanks to a Second Opinion at MSK and a Partial Glossectomy

Thanks to a second opinion and minimally invasive surgery at MSK to remove tongue cancer, Karren Tyler is back home in Charlottesville, Virginia, cancer free and focused on giving back to other cancer patients.
Dr. Charles Rudin
FDA Grants Full Approval to Lung Cancer Drug Tarlatamab Based on Trial Led by MSK Researcher

The U.S. Food and Drug Administration (FDA) has granted full approval to the drug tarlatamab, a bispecific T cell engager, for small cell lung cancer, based on results from a phase 3 clinical trial led by Dr. Charles Rudin at MSK.